Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Malika Ichiche in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Jean-Philippe Praet in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Introduction Thyroid autoimmunity (TAI) and (subclinical) hypothyroidism (SCH) have been associated with adverse pregnancy outcomes, such as miscarriage, preterm birth, and gestational diabetes mellitus (GDM) ( 1 ). TAI and GDM have been
Search for other papers by Emna Jelloul in
Google Scholar
PubMed
Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
) ( 3 , 7 , 9 ). Therefore, the aim of this study was to investigate the impact of sTSH levels during the late first to early second trimester on different maternal and neonatal outcomes (iron deficient anaemia (IDA), gestational diabetes (GDM), PTB
Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea
Search for other papers by Chae Won Chung in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Kyungsik Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Sue K Park in
Google Scholar
PubMed
Search for other papers by Dal Lae Ju in
Google Scholar
PubMed
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Choong Ho Shin in
Google Scholar
PubMed
Search for other papers by Jong Kwan Jun in
Google Scholar
PubMed
Search for other papers by June-Key Chung in
Google Scholar
PubMed
Search for other papers by Yoon Ju Song in
Google Scholar
PubMed
Search for other papers by Young Ah Lee in
Google Scholar
PubMed
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Gi Jeong Cheon in
Google Scholar
PubMed
Search for other papers by Sun Wook Cho in
Google Scholar
PubMed
the proportion of sampling during the 2nd trimester was higher (46.2% vs 32.9%, P = 0.013) compared to singleton pregnancies. As a result, there were no differences in the rates of pregnancy-related hypertensive diseases (PRH), gestational diabetes
Search for other papers by John Lazarus in
Google Scholar
PubMed
Search for other papers by Rosalind S. Brown in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
caution. Recent reports suggest an increased risk for gestational diabetes in SCH. A retrospective study in the USA analysing the medical records (by the International Classification of Diseases-9 codes) of 223,512 singleton pregnancies found an
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
.g., miscarriage, preterm birth, pre-eclampsia, and gestational diabetes), especially in TPO-Ab-positive women and in women with a marked elevation of TSH [ 6 , 35 ]. On the other hand, a limited number of observational studies evaluated the impact on child
Search for other papers by Alex Stagnaro-Green in
Google Scholar
PubMed
levothyroxine is increased. Research over the last 20 years has demonstrated a strong association between SCH and adverse outcomes in the mother, fetus and the offspring. With regard to the mother, SCH has been linked to gestational hypertension, gestational
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
Search for other papers by Jiří Horáček in
Google Scholar
PubMed
Search for other papers by Sylvie Špitálníková in
Google Scholar
PubMed
Search for other papers by Jan Paleček in
Google Scholar
PubMed
Search for other papers by Zdeňka Límanová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Hana Vítková in
Google Scholar
PubMed
diabetes mellitus has been reported ( 12 ), but data on gestational diabetes mellitus (GDM) are not available. The aims of the study were (i) to compare the prevalence of thyroid nodules and cancer in women who underwent two different screening strategies
Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
Department of Medicine, Autonomous University of Barcelona, Badalona, Spain
Search for other papers by Berta Soldevila in
Google Scholar
PubMed
Department of Obstetrics & Gynecology, Germans Trias i Pujol University Hospital, Badalona, Spain
Search for other papers by Inés Velasco in
Google Scholar
PubMed
Search for other papers by Carla Muñoz in
Google Scholar
PubMed
Health Department, Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Generalitat de Catalunya, Badalona, Spain
Search for other papers by Yesika Díaz in
Google Scholar
PubMed
Health Department, Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Generalitat de Catalunya, Badalona, Spain
Search for other papers by Laia Egea-Cortés in
Google Scholar
PubMed
Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
Search for other papers by Laura Ferrer-Escopiñan in
Google Scholar
PubMed
Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
Search for other papers by Alejandra Pérez-Montes de Oca in
Google Scholar
PubMed
Search for other papers by Raquel Martínez-Mondejar in
Google Scholar
PubMed
Health Department, Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Generalitat de Catalunya, Badalona, Spain
Search for other papers by Jordi Casabona in
Google Scholar
PubMed
Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
Department of Medicine, Autonomous University of Barcelona, Badalona, Spain
Search for other papers by Manel Puig-Domingo in
Google Scholar
PubMed
antibodies; BMI, body mass index; FT4, free thyroxine; GDM, gestational diabetes mellitus; GHT, gestational hypertension/preeclampsia; hCG, human chorionic gonadotropin hormone; s.d. , standard deviation; TSH, thyrotropin. Concerning TAI, 37 women
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Hospital de Braga, Braga, Portugal
Search for other papers by Maria Lopes-Pereira in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Anna Quialheiro in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Patrício Costa in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Susana Roque in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
ACMP5 – Associação Centro de Medicina P5 (P5), School of Medicine, University of Minho, Braga, Portugal
Search for other papers by Nadine Correia Santos in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Margarida Correia-Neves in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Ana Goios in
Google Scholar
PubMed
Search for other papers by Ivone Carvalho in
Google Scholar
PubMed
Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed
Search for other papers by Laura Vilarinho in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Clinical Academic Center-Braga (2CA-B), Braga, Portugal
Search for other papers by Joana Almeida Palha in
Google Scholar
PubMed
hypertension and preeclampsia, gestational diabetes, hydramnios, intrauterine growth restriction, placental abruption, small or large for gestational age (defined as birth weight below the 10th and above the 90th percentile, respectively, for gestational age
Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
delivery, gestational diabetes and toxemia was higher than our medical center's average. The incidence of newborn deaths was higher, but not significantly so, than the mean incidence in Israel (8.5 compared to 3.4:1000 live births, CI: 3.1–18.5) ( https